PL1884775T3 - Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1 - Google Patents
Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1Info
- Publication number
- PL1884775T3 PL1884775T3 PL06016296T PL06016296T PL1884775T3 PL 1884775 T3 PL1884775 T3 PL 1884775T3 PL 06016296 T PL06016296 T PL 06016296T PL 06016296 T PL06016296 T PL 06016296T PL 1884775 T3 PL1884775 T3 PL 1884775T3
- Authority
- PL
- Poland
- Prior art keywords
- receptor antibody
- diagnosis
- receptor
- disease involving
- disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000027932 Collagen disease Diseases 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 206010047115 Vasculitis Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000002616 plasmapheresis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Rehabilitation Therapy (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06016296A EP1884775B1 (en) | 2006-08-04 | 2006-08-04 | Method for diagnosis of a disease involving an anti-AT1-receptor antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1884775T3 true PL1884775T3 (pl) | 2010-06-30 |
Family
ID=37401029
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06016296T PL1884775T3 (pl) | 2006-08-04 | 2006-08-04 | Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1 |
| PL07802440T PL2057467T3 (pl) | 2006-08-04 | 2007-07-31 | Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07802440T PL2057467T3 (pl) | 2006-08-04 | 2007-07-31 | Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8425877B2 (pl) |
| EP (2) | EP1884775B1 (pl) |
| AT (2) | ATE454630T1 (pl) |
| DE (1) | DE602006011602D1 (pl) |
| ES (2) | ES2336350T3 (pl) |
| PL (2) | PL1884775T3 (pl) |
| WO (1) | WO2008015218A2 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10123929A1 (de) | 2001-05-11 | 2002-11-21 | Celltrend Gmbh | Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit |
| EP1884776A1 (en) | 2006-08-04 | 2008-02-06 | Celltrend GmbH | Method for diagnosis of a disease involving an anti-endothelin-receptor antibody |
| ES2336350T3 (es) | 2006-08-04 | 2010-04-12 | Celltrend Gmbh | Procedimiento para el diagnostico de una enfermedad que implica un anticuerpo antirreceptor at1. |
| WO2011128324A1 (en) * | 2010-04-12 | 2011-10-20 | Celltrend Gmbh | Method for diagnosis of multiple sclerosis involving anti-at1-receptor antibody |
| US8483415B2 (en) | 2010-06-18 | 2013-07-09 | Motorola Mobility Llc | Antenna system with parasitic element for hearing aid compliant electromagnetic emission |
| US20170082619A1 (en) | 2015-09-23 | 2017-03-23 | One Lambda, Inc. | Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens |
| WO2017075380A1 (en) * | 2015-10-30 | 2017-05-04 | The Johns Hopkins University | Angiotensin receptor autoantibodies as biomarker for effective usage of angiotensin receptor blockers |
| US9989543B2 (en) | 2016-01-11 | 2018-06-05 | Autotelic, Llc | Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension |
| CN108948183B (zh) * | 2018-06-05 | 2022-01-28 | 武汉华纪元生物技术开发有限公司 | α1受体和AT1受体抗原类似物多肽及其抗体检测试剂盒和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2866182B2 (ja) | 1990-10-08 | 1999-03-08 | 日本ケミファ株式会社 | エンドセリン受容体 |
| FR2787330A1 (fr) | 1998-12-18 | 2000-06-23 | Sanofi Sa | Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe |
| EP1141018A2 (de) | 1998-12-24 | 2001-10-10 | Max-Delbrück-Centrum Für Molekulare Medizin | Peptide des at1-rezeptors und ihre verwendung bei präeklampsie und maligner hypertonie |
| DE19954305A1 (de) * | 1998-12-24 | 2000-06-29 | Max Delbrueck Centrum | Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie |
| CA2314811A1 (en) * | 2000-08-02 | 2002-02-02 | Brian Archibald Macvicar | Autoimmunity to angiotensin at1 receptors in schizophrenia |
| DE10123929A1 (de) * | 2001-05-11 | 2002-11-21 | Celltrend Gmbh | Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit |
| US20030078190A1 (en) * | 2001-05-25 | 2003-04-24 | Weinberg Marc S. | Methods for tissue protection using highly effective inhibition of the renin-angiotensin system |
| AU2003293004A1 (en) | 2002-11-29 | 2004-06-23 | Max-Delbruck-Centrum Fur Molekulare Medizin | Identification of agonistic autoantibodies |
| US20060135422A1 (en) * | 2003-04-17 | 2006-06-22 | Moskowitz David W | Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
| WO2006060336A2 (en) | 2004-11-30 | 2006-06-08 | The Johns Hopkins University | Endothelin-2 and retinal damage |
| EP1884776A1 (en) | 2006-08-04 | 2008-02-06 | Celltrend GmbH | Method for diagnosis of a disease involving an anti-endothelin-receptor antibody |
| ES2336350T3 (es) | 2006-08-04 | 2010-04-12 | Celltrend Gmbh | Procedimiento para el diagnostico de una enfermedad que implica un anticuerpo antirreceptor at1. |
-
2006
- 2006-08-04 ES ES06016296T patent/ES2336350T3/es active Active
- 2006-08-04 AT AT06016296T patent/ATE454630T1/de not_active IP Right Cessation
- 2006-08-04 PL PL06016296T patent/PL1884775T3/pl unknown
- 2006-08-04 DE DE602006011602T patent/DE602006011602D1/de active Active
- 2006-08-04 EP EP06016296A patent/EP1884775B1/en active Active
-
2007
- 2007-07-31 US US12/376,164 patent/US8425877B2/en active Active
- 2007-07-31 PL PL07802440T patent/PL2057467T3/pl unknown
- 2007-07-31 WO PCT/EP2007/057910 patent/WO2008015218A2/en not_active Ceased
- 2007-07-31 ES ES07802440T patent/ES2369798T3/es active Active
- 2007-07-31 EP EP07802440A patent/EP2057467B1/en active Active
- 2007-07-31 AT AT07802440T patent/ATE518139T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1884775A1 (en) | 2008-02-06 |
| ES2369798T3 (es) | 2011-12-07 |
| EP1884775B1 (en) | 2010-01-06 |
| PL2057467T3 (pl) | 2011-12-30 |
| WO2008015218A3 (en) | 2008-07-03 |
| EP2057467B1 (en) | 2011-07-27 |
| ATE518139T1 (de) | 2011-08-15 |
| US8425877B2 (en) | 2013-04-23 |
| US20100098688A1 (en) | 2010-04-22 |
| EP2057467A2 (en) | 2009-05-13 |
| DE602006011602D1 (de) | 2010-02-25 |
| WO2008015218A2 (en) | 2008-02-07 |
| ES2336350T3 (es) | 2010-04-12 |
| ATE454630T1 (de) | 2010-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2057467T3 (pl) | Sposób diagnozowania choroby z udziałem przeciwciała przeciwko receptorowi AT1 | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| MX382244B (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales | |
| EP3761034A3 (en) | Urine biomarkers for prediction of recovery after acute kidney injury: proteomics | |
| MX365029B (es) | Biomarcadores de lesion renal. | |
| EP3708682A3 (en) | Use of microvesicles in diagnosis and prognosis of medical diseases and conditions | |
| WO2008122670A3 (en) | Human diabetes susceptibility tnfrsf10b gene | |
| DE602006011896D1 (de) | Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden | |
| EP2069768A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE-2 DIABETES | |
| DE602007007775D1 (de) | Reagenz für hämoglobinabbau | |
| AR086734A1 (es) | Metodos de diagnostico de la enfermedad tromboembolica | |
| EP1960016A4 (en) | PROCESS FOR EXTRACORPORAL REMOVAL OF A PATHOGENIC MICROBE, INFLAMMATORY CELL OR AN INFLAMMATORY PROTEIN FROM BLOOD | |
| EA201300125A1 (ru) | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии | |
| WO2009001545A1 (ja) | 移植片対宿主疾患の検査および治療方法 | |
| EA201490883A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛА К α-СИНУКЛЕИНУ ДЛЯ ДИАГНОСТИКИ ПОВЫШЕННОГО УРОВНЯ α-СИНУКЛЕИНА В МОЗГЕ | |
| CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
| WO2010047938A3 (en) | Mmp activation peptide detection in biological samples | |
| WO2011133036A3 (en) | Means and methods for determining risk of cardiovascular disease | |
| FR2946349B1 (fr) | Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine | |
| ATE528651T1 (de) | Diagnoseverfahren für pulmonale arterielle hypertonie | |
| WO2008145701A9 (en) | Method for predicting the outcome of a critically ill patient | |
| WO2013048174A3 (ko) | Ｃａ19-9, 카텝신 ｄ 및 매트릭스 메탈로프로틴나제-7의 측정수단을 포함하는 췌장암 진단용 키트 | |
| DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| BR112013030646A2 (pt) | uso diagnóstico de pró-somatostatina | |
| WO2008099608A1 (ja) | 炎症性腸疾患の診断方法 |